APA (7th ed.) Citation

Ahrén, B., Simonsson, E., Larsson, H., Landin-Olsson, M., Torgeirsson, H., Jansson, P., . . . Holmes, D. (2002). Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes. Diabetes care, 25(5), 869-875. https://doi.org/10.2337/diacare.25.5.869

Chicago Style (17th ed.) Citation

Ahrén, Bo, et al. "Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes." Diabetes Care 25, no. 5 (2002): 869-875. https://doi.org/10.2337/diacare.25.5.869.

MLA (9th ed.) Citation

Ahrén, Bo, et al. "Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes." Diabetes Care, vol. 25, no. 5, 2002, pp. 869-875, https://doi.org/10.2337/diacare.25.5.869.